Estradiol Valerate/Dienogest: A Novel Combined Oral Contraceptive

Laura M. Borgelt; Chad W. Martell

doi:10.1016/j.clinthera.2011.11.006

Estradiol Valerate/Dienogest: A Novel Combined Oral Contraceptive

Laura M. Borgelt, Chad W. Martell

In: Clinical Therapeutics · 2011 · vol. 34(1) , pp. 37–55 · doi:10.1016/j.clinthera.2011.11.006 · PMID:22169052 · W2031730012

review OA: closed CC0 ⤵ 7 in-corpus citations

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex View on PubMed

⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This paper describes the development and characteristics of estradiol valerate/dienogest, a novel combined oral contraceptive.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (59)

Approaches to the replacement of ethinylestradiol by natural 17β-estradiol in combined oral contraceptives via openalex
Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel via openalex
Effective Treatment of Heavy Menstrual Bleeding With Estradiol Valerate and Dienogest via openalex
Effect of dienogest-containing oral contraceptives on lipid metabolism via openalex
Effect of four oral contraceptives on hemostatic parameters via openalex
Effect of four oral contraceptives on thyroid hormones, adrenal and blood pressure parameters via openalex
Efficacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate/dienogest): A Phase III trial via openalex
Endometrial safety of an oral contraceptive containing estradiol valerate and dienogest via openalex
Estradiol Valerate/Dienogest via openalex
Ethinylestradiol/Dienogest in Oral Contraception via openalex
Evaluation of a new estradiol oral contraceptive: estradiol valerate and dienogest via openalex
Hemostatic Effects of a Novel Estradiol-Based Oral Contraceptive via openalex
O319 A novel oral contraceptive comprising estradiol valerate/dienogest for the treatment of heavy and/or prolonged menstrual bleeding without organic cause: a double‐blind, randomised, placebo‐controlled trial via openalex
Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studies via openalex
Pharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogest via openalex
The pharmacological profile of dienogest via openalex
The use of newer progestins for contraception via openalex
doi:10.1016/s0029-7844(01)01532-0 via openalex
doi:10.1111/j.1471-0528.1979.tb11276.x via openalex
doi:10.1016/s0015-0282(16)56210-4 via openalex
doi:10.3109/00016348709015732 via openalex
doi:10.1358/dot.1999.35.2.527966 via openalex
doi:10.1007/s40278-026-93643-1 via openalex
W2277161029 via openalex
W2287904709 via openalex
W2423459841 via openalex
W2481469001 via openalex
W4285719527 via openalex
W6603819468 via openalex
W6694440177 via openalex
W6721773596 via openalex
W7032893389 via openalex
W7074205359 via openalex
doi:10.3109/13625187.2010.513071 via openalex
doi:10.1016/s0010-7824(96)00183-7 via openalex
doi:10.1016/0378-5122(82)90064-0 via openalex
doi:10.1016/0002-9378(91)90617-z via openalex
doi:10.1016/s0002-9378(99)70718-0 via openalex
doi:10.2165/00003495-200565160-00007 via openalex
doi:10.1016/j.contraception.2006.07.004 via openalex
doi:10.1016/j.ogc.2021.07.001 via openalex
doi:10.4183/aeb.2005.240 via openalex
doi:10.3109/13625187.2010.529969 via openalex
doi:10.1016/j.contraception.2004.05.013 via openalex
doi:10.1016/s0140-6736(79)91525-3 via openalex
doi:10.1016/0010-7824(93)90025-3 via openalex
W94133134 via openalex
W178038234 via openalex
doi:10.1136/bmj.b2921 via openalex
W1907235146 via openalex
doi:10.5694/j.1326-5377.1989.tb136691.x via openalex
doi:10.1016/0378-5122(94)00856-3 via openalex
doi:10.1016/0010-7824(80)90010-4 via openalex
doi:10.1016/j.fertnstert.2010.07.832 via openalex
doi:10.1016/j.ajog.2005.06.010 via openalex
doi:10.1016/j.ejogrb.2010.12.037 via openalex
doi:10.3109/13625180903585431 via openalex
doi:10.1016/s0010-7824(02)00436-5 via openalex
doi:10.1016/j.contraception.2004.12.012 via openalex

Cited by (7)

Source provenance

openalex: last seen: 2026-05-11T06:08:11.709964+00:00

License: CC0 · commercial use OK

[1] Approaches to the replacement of ethinylestradiol by natural 17β-estradiol in combined oral contraceptives via openalex

[2] Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel via openalex

[3] Effective Treatment of Heavy Menstrual Bleeding With Estradiol Valerate and Dienogest via openalex

[4] Effect of dienogest-containing oral contraceptives on lipid metabolism via openalex

[5] Effect of four oral contraceptives on hemostatic parameters via openalex

[6] Effect of four oral contraceptives on thyroid hormones, adrenal and blood pressure parameters via openalex

[7] Efficacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate/dienogest): A Phase III trial via openalex

[8] Endometrial safety of an oral contraceptive containing estradiol valerate and dienogest via openalex

[9] Estradiol Valerate/Dienogest via openalex

[10] Ethinylestradiol/Dienogest in Oral Contraception via openalex

[11] Evaluation of a new estradiol oral contraceptive: estradiol valerate and dienogest via openalex

[12] Hemostatic Effects of a Novel Estradiol-Based Oral Contraceptive via openalex

[13] O319 A novel oral contraceptive comprising estradiol valerate/dienogest for the treatment of heavy and/or prolonged menstrual bleeding without organic cause: a double‐blind, randomised, placebo‐controlled trial via openalex

[14] Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studies via openalex

[15] Pharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogest via openalex

[16] The pharmacological profile of dienogest via openalex

[17] The use of newer progestins for contraception via openalex

[18] doi:10.1016/s0029-7844(01)01532-0 via openalex

[19] doi:10.1111/j.1471-0528.1979.tb11276.x via openalex

[20] doi:10.1016/s0015-0282(16)56210-4 via openalex

[21] doi:10.3109/00016348709015732 via openalex

[22] doi:10.1358/dot.1999.35.2.527966 via openalex

[23] doi:10.1007/s40278-026-93643-1 via openalex

[24] W2277161029 via openalex

[25] W2287904709 via openalex

[26] W2423459841 via openalex

[27] W2481469001 via openalex

[28] W4285719527 via openalex

[29] W6603819468 via openalex

[30] W6694440177 via openalex

[31] W6721773596 via openalex

[32] W7032893389 via openalex

[33] W7074205359 via openalex

[34] doi:10.3109/13625187.2010.513071 via openalex

[35] doi:10.1016/s0010-7824(96)00183-7 via openalex

[36] doi:10.1016/0378-5122(82)90064-0 via openalex

[37] doi:10.1016/0002-9378(91)90617-z via openalex

[38] doi:10.1016/s0002-9378(99)70718-0 via openalex

[39] doi:10.2165/00003495-200565160-00007 via openalex

[40] doi:10.1016/j.contraception.2006.07.004 via openalex

[41] doi:10.1016/j.ogc.2021.07.001 via openalex

[42] doi:10.4183/aeb.2005.240 via openalex

[43] doi:10.3109/13625187.2010.529969 via openalex

[44] doi:10.1016/j.contraception.2004.05.013 via openalex

[45] doi:10.1016/s0140-6736(79)91525-3 via openalex

[46] doi:10.1016/0010-7824(93)90025-3 via openalex

[47] W94133134 via openalex

[48] W178038234 via openalex

[49] doi:10.1136/bmj.b2921 via openalex

[50] W1907235146 via openalex

[51] doi:10.5694/j.1326-5377.1989.tb136691.x via openalex

[52] doi:10.1016/0378-5122(94)00856-3 via openalex

[53] doi:10.1016/0010-7824(80)90010-4 via openalex

[54] doi:10.1016/j.fertnstert.2010.07.832 via openalex

[55] doi:10.1016/j.ajog.2005.06.010 via openalex

[56] doi:10.1016/j.ejogrb.2010.12.037 via openalex

[57] doi:10.3109/13625180903585431 via openalex

[58] doi:10.1016/s0010-7824(02)00436-5 via openalex

[59] doi:10.1016/j.contraception.2004.12.012 via openalex